CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

CorMedix announces preliminary, unaudited financial results for Q4 and FY 2025, including net revenue of approximately $127 million and $310 million, for Q4 2025 and FY 2025, respectively, FY 2025 Pro ...

Understanding Pro Forma vs. GAAP Financial Statements: Key Differences

Discover the crucial differences between pro forma and GAAP financial statements. Learn why companies use both and the ...
TMCnet

LSF12 Helix Parent, LLC Announces Change of Control Offers for Hillenbrand, Inc.'s Senior Notes

The Change of Control Offers are being conducted in connection with the previously announced Agreement and Plan of Merger, dated October 14, 2025, by and among the Company, Parent and LSF12 Helix ...

National Bank Holdings Corporation Completes Acquisition of Vista Bancshares, Inc. and Vista Bank

Immediately following the closing of the merger of Vista with and into NBHC, the combined organization will begin adopting the Vista Bank brand in Texas and incorporate it across the entire enterprise ...
Le Lézard

AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving ...